Select the options below that best describe your investor status

Select your location  -  

Your location is pre-selected based on your location settings

You will be able to select an investor type once a location has been selected.

If none of the above applies to you, please go to our corporate site.

Clicking 'Accept and Enter' means you agree to our investing disclaimers.

Our disclaimer policy

Specific disclaimer policies will be shown here once your location and investor type has been selected.

Martin Currie announces Head of UK Business Development

Mark Elliot

Martin Currie a global active equity specialist headquartered in Edinburgh and part of the Franklin Templeton group, has bolstered its distribution team with the appointment of Mark Elliott as Head of UK Business Development.

Mark will partner closely with Franklin Templeton’s UK sales team to strategically develop its business in the UK retail market across its UK ICVC range, sub-advisory relationships, institutional accounts and closed end funds.

The newly created role reflects the importance of Martin Currie to Franklin Templeton’s UK’s growth ambitions.

Mark is hugely experienced in UK retail market, and joins Martin Currie from Franklin Templeton, where most recently he was Head of Strategic Accounts. Prior to this, he held a number of roles at Blackrock including European Strategy and Head of UK Sales during his decade with them. His 35+ years in UK Financial Services also include 5 years with Lazard Asset Management and 12 years with National IFA, Sedgwick Noble Lowndes in various Advisory and Management roles.

Mel Bucher, Global Head of Distribution said:“UK retail is a critical market for our future growth and Martin Currie is integral to Franklin Templeton’s plan to grow in the UK retail market. We are delighted to have him join the team to further consolidate our presence in the UK and position ourselves as a leading active equity specialist for institutional and intermediary clients. Mark’s experience makes him well-placed to support our efforts.”

Regulatory information and risk warnings

This information is issued and approved by Martin Currie Investment Management Limited (‘MCIM’), authorised and regulated by the Financial Conduct Authority. It does not constitute investment advice. Market and currency movements may cause the capital value of shares, and the income from them, to fall as well as rise and you may get back less than you invested.

The information contained in this document has been compiled with considerable care to ensure its accuracy. However, no representation or warranty, express or implied, is made to its accuracy or completeness. Martin Currie has procured any research or analysis contained in this document for its own use. It is provided to you only incidentally and any opinions expressed are subject to change without notice.

The document does not form the basis of, nor should it be relied upon in connection with, any subsequent contract or agreement. It does not constitute, and may not be used for the purpose of, an offer or invitation to subscribe for or otherwise acquire shares in any of the products mentioned.

Past performance is not a guide to future returns.

The views expressed are opinions of the portfolio managers as of the date of this document and are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. These opinions are not intended to be a forecast of future events, research, a guarantee of future results or investment advice.

The information provided should not be considered a recommendation to purchase or sell any particular strategy / fund / security. It should not be assumed that any of the security transactions discussed here were or will prove to be profitable.

This press release is intended to be of general interest only and does not constitute professional advice. Franklin Templeton and its management groups have exercised professional care and diligence in the collection and processing of the information in this press release. Franklin Templeton makes no representations or warranties with respect to the accuracy of this document. Franklin Templeton shall not be liable to any user of this report or to any other person or entity for the inaccuracy of information contained in this press release or for any errors or omissions in its contents, regardless of the cause of such inaccuracy, error or omission.

Any research and analysis contained in this document has been procured by Franklin Templeton for its own purposes. For more information, UK investors should contact: Franklin Templeton, Cannon Place, 78 Cannon Street, London EC4N 6HL. United Kingdom. Phone: 0800 305 306, Email

Issued by Franklin Templeton Investment Management Limited (FTIML). FTIML is authorised and regulated in the United Kingdom by the Financial Conduct Authority.

Copyright © 2022 Franklin Templeton. All rights reserved.